Search Tag: novel immunotherapies

Executive Health Management

Kineta-appoints-keith-baker-as-chief-financial-officer

2022 04 Oct

Kineta, Inc, a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology announced the appointment of Keith Baker as the Company’s new Chief Financial Officer (CFO). “It is a pleasure to welcome Keith to our management team at this pivotal time for Kineta,” said Shawn Iadonato, Ph.D., Chief Executive Officer...Read more